Resource Library

We’ve compiled a useful collection of resources to learn more about Medrio and various aspects of managing your clinical trial in today’s complex and evolving environment.

  • Filter by Solution

  • Filter by Content

ePRO blog bg
Blog
eCOA / ePRO

Could ePRO Be the New Standard in Health Reimbursement?

January 25, 2023
Healthcare reimbursement is starting to use patient-reported outcomes as proof that a drug or treatment improves the quality of life enough to warrant the cost.
happy business woman optimistic blog bg 2023 01 19
Blog
CDMS / EDCeCOA / ePRO

Is Your CRO’s 2023 Growth Limited by These Four Myths?

January 20, 2023
CROs face growing pressure to differentiate themselves. Myths about sponsor expectations and priorities surrounding eClinical technology can cause CROs to lose bids.
epro webinar bg
Webinar
eCOA / ePRO

Proven Practices for ePRO Adoption

In this webinar Nicole Latimer and Melissa Newara are joined by Dr. Frances Rubenstein from Nevro to discuss how Nevro, a medical device company, implemented ePRO to close gaps in data accuracy, reduce context switching for staff, and enhance patient convenience.
AdobeStock 318663472
Success Story
CDMS / EDC

Heron Therapeutics Speeds Up Database Creation with Medrio EDC

San Diego-based biotech trusts Medrio EDC for data collection. From drag-and-drop features to outstanding support, Medrio offers simplicity without compromise.
10k hours blog bg 2022 11 15
Blog
CDMS / EDC

Does the 10,000-Hours Rule Apply to Clinical Trials?

November 16, 2022
When engaging CROs, sponsors are increasingly prioritizing performance excellence and replicable operating standards.
rtsm blog bg happy user
Blog
RTSM

When Protocol Amendments Meet RTSM – From Headache to High-Performance

November 10, 2022
Protocol amendments are inevitable, but choosing the right RTSM partner can help you navigate study changes with speed and agility.

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.